Skip to main content

Switchable magneto-plasmonic contrast agents and molecular imaging technologies

Project description

Breakthrough magneto-plasmonic imaging technology

The EU-funded SWIMMOT project will establish the scientific and technological basis for radically new in vivo molecular imaging based on a switchable contrast agent (CA) and corresponding optical imaging technology. The CA will be based on novel magnetic core/ plasmonic gold shell nanorods with engineered biofunctional shells. The magneto-plasmonic imaging will switch the CA on and off, resulting in complete removal of the imaging background. This discrimination of the background from the CA signal will yield ultra-high contrast molecular imaging. The technology will enable the in vivo visualisation and quantification of soluble biomarkers at cellular level resolution, surpassing all current capabilities. Developers plan to apply the technology to diabetes research and demonstrate its potential in the zebrafish model.

Call for proposal

H2020-FETOPEN-2018-2019-2020-01
See other projects for this call

Funding Scheme

RIA - Research and Innovation action

Coordinator

AIT AUSTRIAN INSTITUTE OF TECHNOLOGY GMBH
Address
Giefinggasse 4
1210 Wien
Austria
Activity type
Research Organisations
EU contribution
€ 677 917,50

Participants (4)

INSTITUT NATIONAL DES SCIENCES APPLIQUEES DE TOULOUSE
France
EU contribution
€ 841 938,75
Address
Avenue De Rangueil 135
31077 Toulouse
Activity type
Higher or Secondary Education Establishments
UNIVERSIDAD DE SANTIAGO DE COMPOSTELA
Spain
EU contribution
€ 546 035
Address
Colexio De San Xerome Praza Do Obradoiro S/n
15782 Santiago De Compostela
Activity type
Higher or Secondary Education Establishments
MEDIZINISCHE UNIVERSITAET WIEN
Austria
EU contribution
€ 773 727,50
Address
Spitalgasse 23
1090 Wien
Activity type
Higher or Secondary Education Establishments
UNIVERSITAET INNSBRUCK
Austria
EU contribution
€ 626 950
Address
Innrain 52
6020 Innsbruck
Activity type
Higher or Secondary Education Establishments